REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 98 filers reported holding REVANCE THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2014 | $819,000 | – | 26,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
Geduld E E | 25,001 | $850,000 | 0.53% |
Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |